ImmuONE
PrivateLast Round
VC Round
Mar 13, 2025
Total Funding Raised
$2.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImmuONE operates in Healthcare & Life Sciences and is based in Stevenage. Its latest recorded funding round was a VC Round in March 2025.
ImmuONE is a biotechnology company that provides innovative respiratory in vitro cell culture products and contract research services for inhalation safety testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuONE Comparables
Compare ImmuONE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epithelix | 84% | |
| AlveoliX AG | 79% | |
| Dynamic42 | 79% |
For institutional investors. Book with your work email.
ImmuONE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 13, 2025 | ||||
| Seed | Oct 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ImmuONE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Group | Seed, VC Round |
| British Business Bank | Seed, VC Round |
| Mercia Ventures | VC Round, Seed |
| Mercia Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 34% MoM.
- May 19, 2026
Monthly visitors increased 174% MoM, reaching 2K.
For institutional investors. Book with your work email.
ImmuONE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmuONE's valuation, stock price, and market status.
Is ImmuONE a public or private company?
ImmuONE is a private company.
What is the current stock price of ImmuONE?
ImmuONE is a private company, so its shares have no public market price. Caplight tracks ImmuONE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmuONE worth (valuation)?
Valuation information for ImmuONE is not publicly available.
Can I buy ImmuONE stock?
ImmuONE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmuONE's last funding round?
ImmuONE's most recent funding round was VC Round on March 13, 2025.
Who are the main investors in ImmuONE?
Key investors in ImmuONE include Mercia Ventures, Mercia Ventures.
Will ImmuONE IPO soon?
No public IPO plans have been announced for ImmuONE.
How can I track ImmuONE secondary market activity?
Caplight tracks bids, offers, and trades in ImmuONE's shares on secondary markets.